Morning Movers: Apellis slips following negative CHMP opinion

Check out this morning’s top movers from around Wall Street, compiled by The Fly.

HIGHER –

• NovaBay (NBY) up 81% after entering into a definitive asset purchase agreement with Physician Recommended Nutriceuticals to sell the assets of its Avenova brand and business for $9.5M in cash
• Merck (MRK) up 1% after reporting that the EMA’s Committee for Medicinal Products for Human Use adopted opinions recommending approval of Keytruda for two indications in gynecologic cancers
• Battalion Oil (BATL) up 122% after announcing amendment to merger agreement with Fury Resources
• Nike (NKE) up 8% after announcing retirement of CEO John Donahoe with Elliott Hill to succeed

UP AFTER EARNINGS –

• CleanCore Solutions (ZONE) up 4%

DOWN AFTER EARNINGS –

• FedEx (FDX) down 13%
• Lennar (LEN) down 3%
• iPower (IPW) down 1%

LOWER –

• Apellis (APLS) down 7% after announcing that the EMA’s Committee for Medicinal Products for Human Use has confirmed its June 2024 negative opinion on the marketing authorization application of intravitreal pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration